Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Curr Hepatol Rep. 2020 Jul 11;19(3):174–185. doi: 10.1007/s11901-020-00532-y

Figure 1:

Figure 1:

Pathophysiology of Hepatopulmonary Syndrome (A) and Portopulmonary Hypertension (B).

ET: endothelin 1; TNF-alpha: tumor necrosis factor- alpha; IL-6: interleukin-6; NO: nitrous oxide; VEGF: vascular endothelial growth factor; CO: carbon monoxide; AV: arteriovenous; V-Q mismatch: ventilation-perfusion mismatch; R -> L: right to left. Figure made using BioRender graphics.